NASDAQ : SEER
Seer, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 107.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 93.02M |
| Enterprise Value | -37.44M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 55.37M |
| Shares Outstanding | 55.37M |
| Shares Change (YoY) | -6.00% |
| Shares Change (QoQ) | -1.49% |
| Owned by Insiders (%) | 17.50% |
| Owned by Institutions (%) | 42.75% |
| Float | 40.46M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.54 |
| Forward PS | 4.92 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 14.74 |
| Quick Ratio | 13.87 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -26.45% |
| Return on Assets (ROA) | -15.29% |
| Return on Invested Capital (ROIC) | -15.78% |
| Return on Capital Employed (ROCE) | -28.87% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | $114,653 |
| Profits Per Employee | -$548,097 |
| Employee Count | 124 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.98 |
Taxes
| Measure | Value |
|---|
| Income Tax | 71,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -24.32% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 27.37 |
| Average Volume (20 Days) | 200,508 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 94,400 |
| Short Previous Month | 108,598 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 0.31 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 14.22M |
| Gross Profit | 6.78M |
| Operating Income | -70.83M |
| Pretax Income | -67.89M |
| Net Income | -67.96M |
| EBITDA | -64.85M |
| EBIT | -70.83M |
| Loss Per Share | -$1.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 152.85M |
| Total Debt | 22.39M |
| Net Cash | 130.46M |
| Net Cash Per Share | $2.36 |
| Equity (Book Value) | 225.68M |
| Book Value Per Share | 4.08 |
| Working Capital | 154.83M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -43.38M |
| Capital Expenditures | -854,000 |
| Depreciation & Amortization | 5.98M |
| Net Borrowing | n/a |
| Free Cash Flow | -44.23M |
| FCF Per Share | -$0.80 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.70% |
| Operating Margin | -498.19% |
| Pretax Margin | -477.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 6.00% |
| Shareholder Yield | 6.00% |
| Earnings Yield | -72.42% |
| FCF Yield | -47.55% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.00 |
| Price Target Difference | 138.10% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 16.04% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.7 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |